Harvard Endowment Halts IBIT Selloff, Holds $101M Bitcoin Position Flat
Harvard Management Company's Q2 2026 13F shows zero IBIT shares sold or added for the first time since the endowment's peak $443M position in Q3 2025. The trimming cycle is done.
Harvard Management Company's Q2 2026 13F shows the endowment stopped selling Bitcoin after cutting its position by more than half from peak.
Key takeaways
- Harvard Management Company held exactly 3,044,612 IBIT shares through all of Q2 2026, per its August 14 SEC filing, ending two consecutive quarters of aggressive selling that reduced the position 55%+ from its Q3 2025 peak of roughly $443M.
- The dollar value fell from approximately $117M to $101.4M between Q1 and Q2 entirely on price movement. Not a single share was sold.
- IBIT is now Harvard's only digital asset exposure. Its short-lived spot Ethereum ETF position was fully liquidated in Q1 2026, and the endowment now holds more in gold products ($171.2M combined IAU and GLD) than in Bitcoin.
Harvard Management Company's Q2 2026 13F filing, filed August 14 with the SEC, shows the endowment held 3,044,612 shares of BlackRock's iShares Bitcoin Trust (IBIT) valued at $101.4M as of June 30, 2026. That share count is identical to Q1 2026. The selloff is over. The story first reported by The Block.
From $443M to $101M: What the Selling Actually Was
The position history matters for reading the signal correctly.
HMC entered IBIT in Q2 2025 with roughly 1.9 million shares. By Q3 2025 it had scaled to 6,813,612 shares at approximately $443M, a position large enough to rank Harvard among the largest known university holders of a spot Bitcoin ETF. Then came the cuts: Q4 2025 saw a 21% reduction to 5,353,612 shares, Q1 2026 saw another 43% reduction to 3,044,612 shares. Two quarters of deliberate, sizable selling.
Q2 2026: zero movement.
The $15.6M decline in dollar value from Q1 to Q2 is entirely price-driven. HMC made no portfolio decision in Q2 other than to hold. For a multi-generational capital allocator operating through investment committee processes and fiduciary frameworks, that inaction is itself a decision.
IBIT now ranks 11th among HMC's 19 disclosed positions, representing 2.4% of its $4.26B in publicly reported 13F holdings. For scale, Space Exploration Technologies (SPCX), which listed on Nasdaq in June 2026, dominates at $2.21B (52% of disclosed holdings), and combined gold positions in IAU and GLD total $171.2M, ahead of the Bitcoin allocation. Within the digital asset sleeve, IBIT is the entire book. HMC fully exited its BlackRock spot Ethereum ETF (ETHA) position in Q1 2026 after holding it for only one quarter.
The Signal Institutional Allocators Actually Send
The pattern here is worth naming plainly: buy, oversize, right-size, hold.
HMC came in fast in 2025, peaked at a position that represented meaningful scale, then spent two quarters cutting to a level they're comfortable maintaining. A $100M+ IBIT line in a roughly $56.9B endowment (per the most recent HMC annual report, as of June 30, 2025) is a base allocation. The sizing exercise completed; the position stayed.
The institutional flywheel argument around Bitcoin ETFs depends on this kind of outcome. When Harvard initially bought in Q3 2025, it gave air cover to other university CIOs sitting on the sidelines. When it sold aggressively in Q4 2025 and Q1 2026, it created legitimate uncertainty about whether the original thesis held. Now the selling has stopped and the position has been held flat into a broader backdrop of accumulation: Mubadala and ADIC combined held roughly $764M of IBIT at June 30 unchanged in share count, JPMorgan expanded to 10.4M shares, and Morgan Stanley maintained roughly 16.5M shares.
Harvard stabilizing is happening while other large institutional holders are growing their positions, which is the more important data point than any single quarter's share count.
The falsifiable version of this thesis: if HMC's Q3 2026 13F, due in November, shows further share reduction, the "found the floor" read is wrong and the selloff was an ongoing exit, not a sizing correction. Continued selling through year-end would fully falsify the stabilization call. Watch that filing.
The broader question the ETF wrapper raises, and this data point doesn't resolve, is whether institutional Bitcoin exposure through IBIT is building the adoption flywheel or just creating a Wall Street claim on Bitcoin's price action without any of the sovereignty that comes from holding keys directly. Both things can be true simultaneously: the treasury allocation trend is real and growing, and the ETF structure still sits several layers removed from actual Bitcoin ownership.
What to Watch Next
The Q3 2026 13F filing, due in November 2026, is the verification event for the stabilization thesis. Any reduction in share count reopens the question of whether this was a floor or a pause. Meanwhile, the gap between Harvard's $101.4M IBIT allocation and its $171.2M gold exposure tells you where Bitcoin sits in the capital stack hierarchy for this particular allocator: adjacent to gold, not above it. Whether that relationship shifts over the next few quarters is worth tracking.
Sources
- Harvard Management Company SEC EDGAR 13F Filing (Q2 2026)
- First reported by The Block
Frequently Asked Questions
HMC's 13F filings carry no explanatory narrative. No public statement accompanied the trades. Analysts have cited potential factors including portfolio rebalancing, liquidity needs to fund private equity capital calls, and a reassessment of position sizing after the initial entry scaled faster than intended. None of these explanations are confirmed; they're inferences from the filing data.
The 13F covers only U.S.-listed securities held directly. IBIT represents Harvard's entire disclosed digital asset allocation. Whether HMC holds any Bitcoin outside the ETF wrapper is not publicly known and would not appear in a 13F filing.
It's mid-tier by size. Morgan Stanley reported roughly 16.5M shares as of Q2 2026. Mubadala and ADIC combined held approximately $764M.
Paul Tudor Jones' Tudor Investment Corp held 688,529 shares ($22.9M). Harvard's position, while significant for a university endowment, is considerably smaller than the largest sovereign and institutional holders now active in IBIT.
